Antes L M, Fernandez P C
Dis Mon. 1998 Jun;44(6):254-68. doi: 10.1016/s0011-5029(98)90003-7.
This section discusses the reasons different diuretic agents inhibit salt reabsorption at specific sites within the renal tubule. It also includes a brief review of how diuretics reach their target site of action along the nephron, together with a discussion of how disease states may affect the delivery of diuretics to those sites. When diuretics are administered to edematous patients, the natriuretic response is often blunted. In addition, increased renal tubular salt avidity is observed after administration of loop diuretics. The elements required to successfully achieve adequate natriuresis under such conditions are analyzed. Because achieving diuresis may result in significant hypokalemia, hyponatremia, metabolic alkalosis, and worsening prerenal azotemia, the prevention and management of these complications of diuretic therapy are also reviewed. A description of successful use of diuretics in specific edematous states, such as congestive heart failure, chronic renal failure, nephrotic syndrome, and liver disease, is followed by a brief discussion of the management of resistant edema and the use of diuretics in nonedematous states, including essential hypertension and other conditions.
本节讨论了不同利尿剂在肾小管特定部位抑制盐重吸收的原因。还简要回顾了利尿剂如何沿着肾单位到达其作用靶点,以及疾病状态如何影响利尿剂向这些部位的输送。当给水肿患者使用利尿剂时,利钠反应往往会减弱。此外,使用袢利尿剂后会观察到肾小管对盐的亲和力增加。分析了在这种情况下成功实现充分利钠所需的因素。由于利尿可能导致严重的低钾血症、低钠血症、代谢性碱中毒和肾前性氮质血症恶化,因此还回顾了利尿剂治疗这些并发症的预防和管理。在描述利尿剂在特定水肿状态(如充血性心力衰竭、慢性肾衰竭、肾病综合征和肝病)中的成功应用之后,简要讨论了难治性水肿的管理以及利尿剂在非水肿状态(包括原发性高血压和其他疾病)中的应用。